BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20386493)

  • 1. Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate.
    Stamp LK; Chapman PT; O'Donnell JL; Zhang M; James J; Frampton C; Barclay ML; Kennedy MA; Roberts RL
    Pharmacogenet Genomics; 2010 Jun; 20(6):367-76. PubMed ID: 20386493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Folate-Related Gene Polymorphisms on High-Dose Methotrexate-Related Toxicity and Prognosis in Turkish Children with Acute Lymphoblastic Leukemia.
    Yazıcıoğlu B; Kaya Z; Güntekin Ergun S; Perçin F; Koçak Ü; Yenicesu İ; Gürsel T
    Turk J Haematol; 2017 Jun; 34(2):143-150. PubMed ID: 27094381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritis.
    Davis LA; Polk B; Mann A; Wolff RK; Kerr GS; Reimold AM; Cannon GW; Mikuls TR; Caplan L
    Clin Exp Rheumatol; 2014; 32(3):324-32. PubMed ID: 24447348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of intracellular methotrexate kinetics in red blood cells with the kinetics in other cell types.
    Korell J; Duffull SB; Dalrymple JM; Drake J; Zhang M; Barclay ML; Stamp LK
    Br J Clin Pharmacol; 2014 Mar; 77(3):493-7. PubMed ID: 23844933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics.
    Kager L; Cheok M; Yang W; Zaza G; Cheng Q; Panetta JC; Pui CH; Downing JR; Relling MV; Evans WE
    J Clin Invest; 2005 Jan; 115(1):110-7. PubMed ID: 15630450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in folate-dependent one-carbon metabolism as colon cell transition from normal to cancerous.
    Asante I; Chui D; Pei H; Zhou E; De Giovanni C; Conti D; Louie S
    J Nutr Biochem; 2019 Jul; 69():1-9. PubMed ID: 31035100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review of Clinical Applications and Side Effects of Methotrexate in Ophthalmology.
    Wang G; Peng X
    J Ophthalmol; 2020; 2020():1537689. PubMed ID: 32850138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in genes involved in the mechanism of action of methotrexate: are they associated with outcome in rheumatoid arthritis patients?
    Salazar J; Moya P; Altés A; Díaz-Torné C; Casademont J; Cerdà-Gabaroi D; Corominas H; Baiget M
    Pharmacogenomics; 2014 Jun; 15(8):1079-90. PubMed ID: 25084201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis.
    Plaza-Plaza JC; Aguilera M; Cañadas-Garre M; Chemello C; González-Utrilla A; Faus Dader MJ; Calleja MA
    OMICS; 2012 Nov; 16(11):589-95. PubMed ID: 23095111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between single-nucleotide polymorphisms of RFC-1, GGH, MTHFR , TYMS, and TCII genes and the efficacy and toxicity of methotrexate treatment in patients with rheumatoid arthritis.
    Świerkot J; Ślęzak R; Karpiński P; Pawłowska J; Noga L; Szechiński J; Wiland P
    Pol Arch Med Wewn; 2015; 125(3):152-61. PubMed ID: 25599563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia.
    Radtke S; Zolk O; Renner B; Paulides M; Zimmermann M; Möricke A; Stanulla M; Schrappe M; Langer T
    Blood; 2013 Jun; 121(26):5145-53. PubMed ID: 23652803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of methylenetetrahydrofolate reductase gene polymorphisms on the outcome of pediatric patients with non-Hodgkin lymphoma treated with high-dose methotrexate.
    D'Angelo V; Ramaglia M; Iannotta A; Francese M; Pota E; Affinita MC; Pecoraro G; Indolfi C; Di Martino M; Di Pinto D; Buffardi S; Poggi V; Indolfi P; Casale F
    Leuk Lymphoma; 2013 Dec; 54(12):2639-44. PubMed ID: 23488607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of genetic polymorphisms of FPGS, GGH, and MTHFR on serum methotrexate levels in Chinese children with acute lymphoblastic leukemia.
    Wang SM; Sun LL; Zeng WX; Wu WS; Zhang GL
    Cancer Chemother Pharmacol; 2014 Aug; 74(2):283-9. PubMed ID: 24908438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C677T polymorphism in the MTHFR gene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population.
    Cáliz R; del Amo J; Balsa A; Blanco F; Silva L; Sanmarti R; Martínez FG; Collado MD; Ramirez Mdel C; Tejedor D; Artieda M; Pascual-Salcedo D; Oreiro N; Andreu JL; Graell E; Simon L; Martínez A; Mulero J
    Scand J Rheumatol; 2012 Feb; 41(1):10-4. PubMed ID: 22044028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between the genetic polymorphisms of MTHFR and outcomes of methotrexate treatment in rheumatoid arthritis.
    Xiao H; Xu J; Zhou X; Stankovich J; Pan F; Zhang Z; Xu S; Lian L; Ding C
    Clin Exp Rheumatol; 2010; 28(5):728-33. PubMed ID: 20863444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTHFR functional genetic variation and methotrexate treatment response in rheumatoid arthritis: a meta-analysis.
    Morgan MD; Al-Shaarawy N; Martin S; Robinson JI; Twigg S; ; Magdy AA; Omar AS; Ghattas MH; Emery P; Barrett JH; Morgan AW
    Pharmacogenomics; 2014 Mar; 15(4):467-75. PubMed ID: 24624914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide analysis of methotrexate pharmacogenomics in rheumatoid arthritis shows multiple novel risk variants and leads for TYMS regulation.
    Senapati S; Singh S; Das M; Kumar A; Gupta R; Kumar U; Jain S; Juyal RC; Thelma BK
    Pharmacogenet Genomics; 2014 Apr; 24(4):211-9. PubMed ID: 24583629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study.
    Iannaccone CK; Lee YC; Cui J; Frits ML; Glass RJ; Plenge RM; Solomon DH; Weinblatt ME; Shadick NA
    Rheumatology (Oxford); 2011 Jan; 50(1):40-6. PubMed ID: 20847201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate.
    Jabeen S; Holmboe L; Alnæs GI; Andersen AM; Hall KS; Kristensen VN
    Pharmacogenomics J; 2015 Oct; 15(5):385-90. PubMed ID: 25778468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients.
    Soukup T; Dosedel M; Pavek P; Nekvindova J; Barvik I; Bubancova I; Bradna P; Kubena AA; Carazo AF; Veleta T; Vlcek J
    Rheumatol Int; 2015 Jul; 35(7):1149-61. PubMed ID: 25618758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.